SIGN UPLog In

General

Financials

People

Founders
Employee Profiles

Activity

Recent News
Asher Bio
Asher Bio
Company

Last deal

$55M

Amount

Series C

Stage

16.04.2024

Date

3

all rounds

$218.15M

Total amount

date founded

Financing round

General

About Company
Asher Bio builds better immunotherapy for cancer.

Industry

Sector :

Subsector :

founded date

01.01.2019

founders

Number of employees

1-10

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

Asher Bio is a biotechnology company headquartered in San Francisco that develops immunotherapy drugs to treat cancer. The company's drugs are designed to ramp up the immune system to take on cancer cells with precision and minimal side effects, allowing doctors to treat patients quickly. In addition to its work in biotechnology, Asher Bio also specializes in CFO Office transformation, profitability, and cost management through its information technology services. Founded in 2019, the company is committed to improving cancer treatment through innovative therapies.
Contacts

location

San Francisco, CA, USA

Contact Email

Phone number

Website URL

https://www.asherbio.com/

Social url

Legal Names

Legal name

Asher Biotherapeutics,Inc
Similar Companies
1000
PairX Bio
PairX BioPairX Bio is developing cancer immunotherapies.
PairX Bio

PairX Bio

PairX Bio is developing cancer immunotherapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Singapore
Diaccurate
DiaccurateDiaccurate is a French biotech company that develops novel therapeutic approaches to treat incurable cancers.
Diaccurate

Diaccurate

Diaccurate is a French biotech company that develops novel therapeutic approaches to treat incurable cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Paris, France

total rounds

1
Bullet Biotechnology
Bullet BiotechnologyBullet Biotechnology develops immunotherapies to improve a patient's immune system to fight diseases.
Bullet Biotechnology

Bullet Biotechnology

Bullet Biotechnology develops immunotherapies to improve a patient's immune system to fight diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Menlo Park, CA, USA

total rounds

3

total raised

$2.18M
Advaxis
AdvaxisAdvaxis develops cancer immunotherapies that redirect the immune system to kill cancer.
Advaxis

Advaxis

Advaxis develops cancer immunotherapies that redirect the immune system to kill cancer.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Princeton, NJ, USA

total rounds

13

total raised

$156.18M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$218.15M

Money Raised

Their latest funding was raised on 16.04.2024. Their latest investor AstraZeneca. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
16.04.2024
Series C
7
$55M
RA Capital Management
RA Capital Management
01.09.2021
Series B
10
$108M
Wellington Management
Wellington Management
23.03.2021
Series A
5
$55M
Third Rock Ventures
Third Rock Ventures
RA Capital Management

RA Capital Management

RA Capital Management is a Boston-based investment advisor that specializes in the life-sciences and drug development sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Health Care, Financial Services

Location

Boston, MA, USA

count Of Investments

381

count Of Exists

33
Wellington Management

Wellington Management

Wellington Management manages over $1 trillion for clients in 60 countries.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Property Management

Location

Boston, MA, USA

count Of Investments

221

count Of Exists

32
Third Rock Ventures

Third Rock Ventures

Third Rock Ventures invests in high-growth potential life science companies that can make a difference in the marketplace.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Venture Capital, Financial Services, Medical

Location

Boston, MA, USA

count Of Investments

109

count Of Exists

11
Co-Investors
Investors
16
3

Number of lead investors

16

Number of investors

Investor 
Lead 
Round 
Partners 
AstraZeneca
AstraZeneca
No
Series C
—
Boxer Capital
Boxer Capital
No
Series A, Series B, Series C
—
Wellington Management
Wellington Management
Yes
Series B, Series C
—
AstraZeneca

AstraZeneca

AstraZeneca is a global biopharmaceutical company that develops innovative prescription medicines.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Location

Cambridge, UK

total rounds

3

total raised

$5.27B

count Of Investments

47

count Of Exists

1
Boxer Capital

Boxer Capital

Boxer Capital supports biotech public companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Windermere, FL 34786, USA

count Of Investments

91

count Of Exists

7
Wellington Management

Wellington Management

Wellington Management manages over $1 trillion for clients in 60 countries.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Health Care, Property Management

Location

Boston, MA, USA

count Of Investments

221

count Of Exists

32

People

Founders
2
Ivana Djuretic
Ivana Djuretic

Ivana Djuretic

Ivana Djuretic is the CEO of Asher Bio.

current job

Asher Bio
Asher Bio

organization founded

1
Ivana Djuretic

Ivana Djuretic

Andy Yeung
Andy Yeung

Andy Yeung

Andy Yeung is the Founder and Chief Technology Officer of Asher Bio. He was a Founder of Y Combinator before that.

current job

Asher Bio
Asher Bio

organization founded

1
Andy Yeung

Andy Yeung

Employee Profiles
4
Andrea Pirzkall
Andrea Pirzkall

Andrea Pirzkall

Chief Medical Officer

Chief Medical Officer

Craig Gibbs
Craig Gibbs

Craig Gibbs

Chief Executive Officer

Chief Executive Officer

Andy Yeung
Andy Yeung

Andy Yeung

Chief Technology Officer, Founder

Chief Technology Officer, Founder

Ivana Djuretic
Ivana Djuretic

Ivana Djuretic

Co-Founder, Chief Scientific Officer

Co-Founder, Chief Scientific Officer

Activity

Recent News
2
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month